US OptionsDetailed Quotes
AMED250117P80000
- 1.40
- -0.30-17.65%
15min DelayClose Dec 24 13:00 ET
1.40High1.40Low
1.40Open1.70Pre Close1 Volume4.77K Open Interest80.00Strike Price140.00Turnover42.77%IV7.69%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry1.40Extrinsic Value100Contract SizeAmericanOptions Type-0.2563Delta0.0350Gamma56.77Leverage Ratio-0.0615Theta-0.0135Rho-14.55Eff Leverage0.0693Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?